These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18592004)

  • 1. Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.
    Toma MI; Grosser M; Herr A; Aust DE; Meye A; Hoefling C; Fuessel S; Wuttig D; Wirth MP; Baretton GB
    Neoplasia; 2008 Jul; 10(7):634-42. PubMed ID: 18592004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors.
    Monzon FA; Hagenkord JM; Lyons-Weiler MA; Balani JP; Parwani AV; Sciulli CM; Li J; Chandran UR; Bastacky SI; Dhir R
    Mod Pathol; 2008 May; 21(5):599-608. PubMed ID: 18246049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for routine clinical use on formalin-fixed paraffin-embedded tissues.
    Lyons-Weiler M; Hagenkord J; Sciulli C; Dhir R; Monzon FA
    Diagn Mol Pathol; 2008 Mar; 17(1):3-13. PubMed ID: 18303412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array.
    Hu N; Wang C; Hu Y; Yang HH; Kong LH; Lu N; Su H; Wang QH; Goldstein AM; Buetow KH; Emmert-Buck MR; Taylor PR; Lee MP
    BMC Genomics; 2006 Nov; 7():299. PubMed ID: 17134496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations in renal cell carcinoma with rhabdoid differentiation.
    Perrino CM; Hucthagowder V; Evenson M; Kulkarni S; Humphrey PA
    Hum Pathol; 2015 Jan; 46(1):9-16. PubMed ID: 25439741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.
    Chen M; Ye Y; Yang H; Tamboli P; Matin S; Tannir NM; Wood CG; Gu J; Wu X
    Int J Cancer; 2009 Nov; 125(10):2342-8. PubMed ID: 19521957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays.
    Argos M; Kibriya MG; Jasmine F; Olopade OI; Su T; Hibshoosh H; Ahsan H
    Cancer Genet Cytogenet; 2008 Apr; 182(2):69-74. PubMed ID: 18406867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
    Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
    Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays.
    Harada T; Chelala C; Bhakta V; Chaplin T; Caulee K; Baril P; Young BD; Lemoine NR
    Oncogene; 2008 Mar; 27(13):1951-60. PubMed ID: 17952125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma.
    Yoshimoto T; Matsuura K; Karnan S; Tagawa H; Nakada C; Tanigawa M; Tsukamoto Y; Uchida T; Kashima K; Akizuki S; Takeuchi I; Sato F; Mimata H; Seto M; Moriyama M
    J Pathol; 2007 Dec; 213(4):392-401. PubMed ID: 17922474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copy Number Alterations with Prognostic Potential in Clear Cell Renal Cell Carcinoma.
    Maruschke M; Koczan D; Ziems B; Hakenberg OW
    Urol Int; 2018; 101(4):417-424. PubMed ID: 30227442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile.
    Cifola I; Spinelli R; Beltrame L; Peano C; Fasoli E; Ferrero S; Bosari S; Signorini S; Rocco F; Perego R; Proserpio V; Raimondo F; Mocarelli P; Battaglia C
    Mol Cancer; 2008 Jan; 7():6. PubMed ID: 18194544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
    Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
    Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping array.
    Zhou X; Mok SC; Chen Z; Li Y; Wong DT
    Hum Genet; 2004 Sep; 115(4):327-30. PubMed ID: 15290239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma.
    Chino K; Esumi M; Ishida H; Okada K
    J Urol; 1999 Aug; 162(2):614-8. PubMed ID: 10411097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.